As the COVID-19 (novel coronavirus) crisis worsens around the world, rheumatic disease patient organizations and the patients are looking to help. Be part of an effort that “unlocks” the COVID-19 code. The COVID-19 pandemic has quickly infected more than a million people. While most people with COVID-19 infections have mild or no symptoms, a significant proportion of patients can become quite ill. At this time, little is known about how patients with rheumatic diseases, many of whom use medications and drugs that suppress the immune system, are affected by the virus.
The COVID-19 Global Rheumatology Alliance is calling on people 18 years of age and older with rheumatic diseases, and parents of children with rheumatic diseases to participate in a survey so that we may learn how best to prevent or treat COVID-19 in this population. Patients with rheumatic diseases with or without COVID-19 infection are eligible to participate. The survey is being managed by doctors and researchers from Boston Children’s Hospital and Harvard Medical School. All information collected in the survey is completely anonymous and protected.
Help the Alliance “Unlock the COVID-19 Code” by completing the Patient Experience Survey